|
|
1. MARKET OVERVIEW
|
Influencer Market Insights |
World Market Trajectories |
Competent Cells – Global Key Competitors Percentage Market Share in 2022 (E) |
Competent Cells Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Impact of Covid-19 and a Looming Global Recession |
Clean-Label Starch Innovations
|
Chemically Competent Cells Segment Dominate in North America
|
Drivers & Restrains Summarized for Competent Cells Market
|
Cloning is Expected to Take the Largest Share of Competent Cells Market
|
Competent Cells Growth Outlook
|
Competent Cells Application Trends
|
Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market
|
Leading Players in competent cells market
|
2. FOCUS ON SELECT PLAYERS
|
3. MARKET TRENDS & DRIVERS
|
Advancements in Molecular Cloning Drives Competent Cell Market |
Drivers and Restraints Summarised |
SGI-DNA Inc has Launched Vmax™ Express Chemically Competent Cells . |
Increasing Research on Cloning Demands Competent Cells Requirement |
Increasing Intensity of Research and Technological Advancements Drives Market |
Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022 |
As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells |
Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022 |
As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells |
Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins |
Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells |
Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells |
Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth |
Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods |
Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method |
Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells |
Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth |
Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery |
Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030 |
Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth |
4. GLOBAL MARKET PERSPECTIVE
|
World Recent Past, Current & Future Analysis for Competent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Chemically Competent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Chemically Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Electrocompetent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Electrocompetent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Protein Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Protein Expression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Competent Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030 |
World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
|
UNITED STATES
|
Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
USA Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
CANADA
|
Canada Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
JAPAN
|
Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Japan Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
CHINA
|
Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
China Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
China Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
China Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
EUROPE
|
Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Europe Recent Past, Current & Future Analysis for Competent Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
Europe 8-Year Perspective for Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
FRANCE
|
Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) |
France Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
France Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
France Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
GERMANY
|
Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
ITALY
|
Italy Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
UNITED KINGDOM
|
Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
REST OF EUROPE
|
Rest of Europe Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
ASIA-PACIFIC
|
Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
REST OF WORLD
|
Rest of World Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of World 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of World 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of World 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030 |
|
|